Plasma exosomes in OSA patients promote endothelial senescence: effect of long-term adherent continuous positive airway pressure
Resumen: Obstructive sleep apnea (OSA) is associated with increased risk for end-organ morbidities, which can collectively be viewed as accelerated aging. Vascular senescence is an important contributor to end-organ dysfunction. Exosomes are released ubiquitously into the circulation, and transfer their cargo to target cells facilitating physiological and pathological processes. Plasma exosomes from 15 patients with polysomnographically diagnosed OSA at baseline (OSA-T1) after 12 months of adherent continuous positive airway pressure (CPAP) treatment (OSA-T2), 13 untreated OSA patients at 12-month intervals (OSA-NT1, OSA-NT2), and 12 controls (CO1 and CO2) were applied on naïve human microvascular endothelialcells-dermal (HMVEC-d). Expression of several senescence gene markers including p16 (CDKN2A), SIRT1, and SIRT6 and immunostaining for ß-galactosidase activity (x-gal) were performed. Endothelial cells were also exposed to intermittent hypoxia (IH) or normoxia (RA) or treated with hydrogen peroxide (H2O2), stained with x-gal and subjected to qRT-PCR. Exosomes from OSA-T1, OSA-NT1, and OSA-NT2 induced significant increases in x-gal staining compared to OSA-T2, CO1, and CO2 (p-value < 0.01). p16 expression was significantly increased (p < 0.01), while SIRT1 and SIRT6 expression levels were decreased (p < 0.02 and p < 0.009). Endothelial cells exposed to IH or to H2O2 showed significant increases in x-gal staining (p < 0.001) and in senescence gene expression. Circulating exosomes in untreated OSA induce marked and significant increases in senescence of naïve endothelial cells, which are only partially reversible upon long-term adherent CPAP treatment. Furthermore, endothelial cells exposed to IH or H2O2 also elicit similar responses. Thus, OSA either directly or indirectly via exosomes may initiate and exacerbate cellular aging, possibly via oxidative stress-related pathways.
Idioma: Inglés
DOI: 10.1093/sleep/zsz217
Año: 2020
Publicado en: Sleep 43, 2 (2020), zsz217 [12 pp.]
ISSN: 0161-8105

Originalmente disponible en: Texto completo de la revista

Factor impacto JCR: 5.849 (2020)
Categ. JCR: NEUROSCIENCES rank: 56 / 273 = 0.205 (2020) - Q1 - T1
Categ. JCR: CLINICAL NEUROLOGY rank: 33 / 208 = 0.159 (2020) - Q1 - T1

Factor impacto SCIMAGO: 2.222 - Physiology (medical) (Q1) - Neurology (clinical) (Q1)

Financiación: info:eu-repo/grantAgreement/ES/ISCIII/FIS/PI12-02175
Financiación: info:eu-repo/grantAgreement/ES/ISCIII/FIS/PI15-01940
Tipo y forma: Article (PostPrint)
Área (Departamento): Area Medicina (Dpto. Medicina, Psiqu. y Derm.)
Exportado de SIDERAL (2025-01-20-14:52:59)


Visitas y descargas

Este artículo se encuentra en las siguientes colecciones:
articulos > articulos-por-area > medicina



 Notice créée le 2025-01-20, modifiée le 2025-01-20


Postprint:
 PDF
Évaluer ce document:

Rate this document:
1
2
3
 
(Pas encore évalué)